Ryerson (RYI)
(Delayed Data from NYSE)
$30.66 USD
-0.39 (-1.26%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $30.63 -0.03 (-0.10%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMFundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
RYI 30.66 -0.39(-1.26%)
Will RYI be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for RYI based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for RYI
Ryerson's (RYI) Q4 Earnings Beat, Revenues Miss Estimates
Ryerson Holding (RYI) to Report Q4 Earnings: What's in the Offing?
RYI: What are Zacks experts saying now?
Zacks Private Portfolio Services
Ryerson Holding (RYI) Suffers a Larger Drop Than the General Market: Key Insights
Ryerson Holding (RYI) Rises Higher Than Market: Key Facts
Ryerson Holding (RYI) Advances While Market Declines: Some Information for Investors
Other News for RYI
Promising Clinical Trial Results Reinforce Buy Rating for Viracta Therapeutics
Warning: RYI is at high risk of performing badly
Ryerson to Host Earnings Call on Wednesday, May 1st, to Discuss First Quarter 2024 Results
Warning: RYI is at high risk of performing badly
Insider Sell: Chief Information Officer Alagu Sundarrajan Sells 10,000 Shares of Ryerson ...